Skip to main content

Saturn Medic

Question Bank

Neuromuscular Blocking Drugs — Autonomic Pharmacology

Pharmacology Question Bank

Free preview — 5 of 30 Neuromuscular Blocking Drugs questions. Create a free student account to unlock all 30 questions in this topic.
Create free account
Pharmacology Question Bank
Neuromuscular Blocking Drugs
Autonomic Pharmacology · Neuromuscular Blocking Drugs · medium
Question 1 of 5
20% complete
0 s
Q1
Accuracy
No answers yet
Quick Tip
Question Navigator
Current
Correct
Incorrect
Unanswered

Neuromuscular Blocking Drugs MCQs: practice questions

Sample Neuromuscular Blocking Drugs multiple-choice questions from Autonomic Pharmacology.

  1. Which drug or drug class is best associated with nondepolarizing blocker inactivated spontaneously in plasma; laudanosine may accumulate?

    • A. Succinylcholine
    • B. Atracurium
    • C. Pancuronium
    • D. Vecuronium
    • E. Rocuronium
  2. Which drug or drug class is best associated with treats malignant hyperthermia by reducing calcium release from skeletal muscle?

    • A. Vecuronium
    • B. Succinylcholine
    • C. Pancuronium
    • D. Dantrolene
    • E. Rocuronium
  3. Which drug or drug class is best associated with intermediate-duration nondepolarizing neuromuscular blocker?

    • A. Rocuronium
    • B. Succinylcholine
    • C. Pancuronium
    • D. Vecuronium
    • E. Atracurium
  4. Which option matches this pharmacology association: depolarizing nicotinic agonist causing persistent endplate depolarization?

    • A. Atracurium
    • B. Pancuronium agent
    • C. Vecuronium
    • D. Rocuronium
    • E. Succinylcholine
  5. Which option matches this pharmacology association: can reverse paralysis caused by nondepolarizing neuromuscular blockers?

    • A. Pancuronium
    • B. Succinylcholine
    • C. Neostigmine
    • D. Vecuronium
    • E. Rocuronium
  6. Which drug is associated with the following clinical use or pharmacologic role: nondepolarizing blocker producing less histamine release and less laudanosine than atracurium?

  7. Which drug or drug class is best associated with intermediate-duration nondepolarizing neuromuscular blocker?

  8. Which drug or drug class is best associated with can potentiate neuromuscular blockade by inhibiting prejunctional acetylcholine release?

  9. Which drug is associated with the following clinical use or pharmacologic role: can potentiate neuromuscular blockade by inhibiting prejunctional acetylcholine release?

  10. Which option matches this pharmacology association: treats malignant hyperthermia by reducing calcium release from skeletal muscle?

  11. Which drug or drug class is best associated with long-acting nondepolarizing neuromuscular blocker?

  12. Which drug is associated with the following clinical use or pharmacologic role: short-acting nondepolarizing blocker hydrolyzed by plasma cholinesterase?

  13. Which option matches this pharmacology association: short-acting nondepolarizing blocker hydrolyzed by plasma cholinesterase?

  14. Which drug is associated with the following clinical use or pharmacologic role: treats malignant hyperthermia by reducing calcium release from skeletal muscle?

  15. Which drug is associated with the following clinical use or pharmacologic role: intermediate-duration nondepolarizing neuromuscular blocker?

  16. Which option matches this pharmacology association: intermediate-duration nondepolarizing neuromuscular blocker?

  17. Which drug or drug class is best associated with can reverse paralysis caused by nondepolarizing neuromuscular blockers?

  18. Which drug is associated with the following clinical use or pharmacologic role: can reverse paralysis caused by nondepolarizing neuromuscular blockers?

  19. Which drug is associated with the following clinical use or pharmacologic role: depolarizing nicotinic agonist causing persistent endplate depolarization?

  20. Which drug or drug class is best associated with short-acting nondepolarizing blocker hydrolyzed by plasma cholinesterase?

  21. Which drug or drug class is best associated with depolarizing nicotinic agonist causing persistent endplate depolarization?

  22. Which option matches this pharmacology association: can potentiate neuromuscular blockade by inhibiting prejunctional acetylcholine release?

  23. Which drug is associated with the following clinical use or pharmacologic role: long-acting nondepolarizing neuromuscular blocker?

  24. Which option matches this pharmacology association: long-acting nondepolarizing neuromuscular blocker?

  25. Which drug is associated with the following clinical use or pharmacologic role: intermediate-duration nondepolarizing neuromuscular blocker?

  26. Which drug or drug class is best associated with nondepolarizing blocker producing less histamine release and less laudanosine than atracurium?

  27. Which drug is associated with the following clinical use or pharmacologic role: nondepolarizing blocker inactivated spontaneously in plasma; laudanosine may accumulate?

  28. Which option matches this pharmacology association: nondepolarizing blocker producing less histamine release and less laudanosine than atracurium?

  29. Which option matches this pharmacology association: nondepolarizing blocker inactivated spontaneously in plasma; laudanosine may accumulate?

  30. Which option matches this pharmacology association: intermediate-duration nondepolarizing neuromuscular blocker?

SaturnMedic